Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

George Van Osten

Orthopaedic Surgery Tupelo, MS Medical Doctor

NPI 1174768287 CMS profile 98428

4381 South Eason Blvd., Suite 303, North Mississippi Sports Medicine And Orthopaedic Clini, Tupelo, MS 38801

Open in the dashboard

General payments

$321,697

371 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, George Van Osten of Tupelo, MS is reported in the CMS Open Payments database as having received $321,697 across 371 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $68,459 71
2024 General $21,033 20
2023 General $28,174 40
2022 General $53,244 73
2021 General $49,769 58
2020 General $41,995 30
2019 General $59,022 79

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • George Van Osten
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to George Van Osten were reported at $68,459. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year George Van Osten Orthopaedic Surgery median Middle half National median
2019 $59,022 $644 $140–$2,844 $163
2020 $41,995 $312 $75–$1,860 $114
2021 $49,769 $520 $117–$2,495 $132
2022 $53,244 $598 $128–$2,731 $149
2023 $28,174 $461 $128–$2,264 $160
2024 $21,033 $497 $134–$2,475 $164
2025 $68,459 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Zimmer Biomet Holdings, Inc. $243,889 276 payments
  2. MedShape, Inc. $30,652 2 payments
  3. Kerecis Limited $23,456 24 payments
  4. CurvaFix, Inc. $21,084 10 payments
  5. Medical Device Business Services, Inc. $1,395 5 payments
  6. Amgen Inc. $298 19 payments
  7. Bioventus LLC $205 11 payments
  8. Smith+Nephew, Inc. $133 6 payments
  9. Skeletal Dynamics Inc $121 2 payments
  10. Radius Health, Inc. $99 4 payments
  11. Other $365 12 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $194,063 82 payments
  2. Education $36,059 15 payments
  3. Acquisitions $28,152 1 payment
  4. Travel and Lodging $25,272 112 payments
  5. Honoraria $17,073 6 payments
  6. Compensation for serving as faculty or as a speaker for a medical education program $12,578 3 payments
  7. Food and Beverage $5,714 150 payments
  8. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $2,788 2 payments
Products named General payments · program years 2019–2025
  1. Affixus Trauma $58,068 94 payments
  2. Affixus Trauma $48,300 51 payments
  3. NCB $43,299 18 payments
  4. Alps Elbow $36,092 24 payments
  5. DVR Anatomic Kickstand $35,625 17 payments
  6. NCB Instruments/Plates/Screws $35,479 22 payments
  7. Alps Prox Tib Plates $29,152 19 payments
  8. Kerecis SurgiClose Wound Care $23,142 21 payments
  9. Kerecis GraftGuide $23,142 21 payments
  10. Kerecis SurgiClose Wound Care $23,142 21 payments
  11. Other $153,226 241 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

13

Median for Orthopedic Surgery: 203

Drug cost

$82

Median for Orthopedic Surgery: $1,433

Branded share of claims

100%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 13 $82

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 69 billing codes

Paid by Medicare

$79,086

Medicare's payments for the services billed

Medicare patients

129

Average age 75

Services billed

1,099

97 women, 32 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 67%
Osteoporosis 44%
Depression 42%
Chronic kidney disease 38%
Diabetes 37%
Ischemic heart disease 35%
COPD 31%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

2 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Prolia
  • Amgen Inc. $22
$22 — —
EVENITY
  • Amgen Inc. $7
$7 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

371 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Mississippi

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record